Methyldrostanolone Research Overview
Pro-Superdrol 10mg Beligas is a methylated anabolic steroid compound designed for laboratory research applications. Methyldrostanolone belongs to the dihydrotestosterone (DHT) derivative class, featuring structural modifications that enhance oral bioavailability and resistance to hepatic metabolism. This research compound exhibits potent androgenic receptor binding affinity in preclinular models, making it valuable for investigating anabolic pathways and steroid receptor interactions. Research scientists studying androgenic modulation mechanisms utilise this compound to examine tissue-selective anabolic effects and metabolic pathway influences. The methylation at the 17α position provides stability for oral research protocols while maintaining high bioactivity in laboratory conditions.
Researchers at Stroid UK Shop have access to comprehensive analytical support for methyldrostanolone studies, with each batch accompanied by third-party verification documentation. The compound’s unique structural characteristics make it particularly suitable for investigating dose-response relationships in androgenic receptor research and comparative studies against other oral steroid compounds. Laboratory protocols examining protein synthesis pathways, nitrogen retention mechanisms, and cellular anabolic signalling cascades benefit from the compound’s consistent bioactivity profile and reliable research outcomes.
Laboratory Research Applications
Methyldrostanolone research encompasses multiple scientific domains including endocrinology, pharmacology, and biochemistry studies. Research teams investigate the compound’s interaction with androgen receptors, examining binding kinetics and downstream signalling pathway activation in cellular models. Comparative pharmacological studies utilise Pro-Superdrol to evaluate potency ratios against reference androgens, providing valuable data for structure-activity relationship research. Laboratory investigations focus on hepatic enzyme induction patterns, particularly examining 17α-methylation effects on metabolic stability and clearance pathways.
Advanced research protocols examine the compound’s effects on gene expression profiles, particularly investigating myofibrillar protein synthesis regulation and satellite cell activation mechanisms. Studies incorporating SARM compounds often utilise methyldrostanolone as a positive control for androgenic activity comparisons. Research examining glucocorticoid receptor antagonism and cortisol pathway modulation benefit from the compound’s documented anti-catabolic properties. Peptide research frequently incorporates steroid compounds to investigate synergistic pathway interactions and comparative mechanism studies.
Product Specifications
| Parameter | Specification |
|---|---|
| Chemical Name | 2α,17α-dimethyl-5α-androstan-17β-ol-3-one |
| Molecular Formula | C₂₁H₃₄O₂ |
| Molecular Weight | 318.49 g/mol |
| CAS Number | 3381-88-2 |
| Dosage Form | 10mg oral tablets |
| Storage Conditions | Room temperature, dry environment |
| Purity Grade | Research grade (verify with COA) |
| Solubility | Ethanol, DMSO, limited aqueous solubility |
Research Compliance Statement
Pro-Superdrol 10mg Beligas methyldrostanolone tablets are manufactured exclusively for in-vitro laboratory research purposes and are not approved for human consumption, therapeutic use, or any clinical applications. This product is intended solely for qualified research institutions and licensed laboratories conducting legitimate scientific studies under appropriate biosafety protocols. Researchers must maintain proper documentation, institutional oversight, and adherence to local regulations governing controlled substance research. All studies involving this compound must comply with institutional review board requirements and applicable research ethics guidelines for laboratory-based investigations.
